|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003241,
umls-concept:C0004083,
umls-concept:C0009566,
umls-concept:C0017968,
umls-concept:C0024141,
umls-concept:C0030705,
umls-concept:C0033105,
umls-concept:C0033621,
umls-concept:C0033706,
umls-concept:C0059249,
umls-concept:C0072393,
umls-concept:C0087086,
umls-concept:C0330390
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-5-25
|
|
pubmed:abstractText |
Anti-phospholipid (aPL) antibodies (Abs) frequently found in the plasma of patients with systemic lupus erythematosus (SLE) have been associated with thrombotic complications. Our aim was to clarify the roles in thrombosis of aPL Abs that react with complexes of phospholipids and plasma proteins such as beta(2)-glycoprotein I (beta(2)-GPI), prothrombin, protein C, protein S, and annexin V.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Annexin A5,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anticardiolipin,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antiphospholipid,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Lupus Coagulation Inhibitor,
http://linkedlifedata.com/resource/pubmed/chemical/Protein C,
http://linkedlifedata.com/resource/pubmed/chemical/Protein S,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Glycoprotein I
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0009-9147
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1008-15
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11375285-Adolescent,
pubmed-meshheading:11375285-Adult,
pubmed-meshheading:11375285-Aged,
pubmed-meshheading:11375285-Annexin A5,
pubmed-meshheading:11375285-Antibodies, Anticardiolipin,
pubmed-meshheading:11375285-Antibodies, Antiphospholipid,
pubmed-meshheading:11375285-Child,
pubmed-meshheading:11375285-Female,
pubmed-meshheading:11375285-Glycoproteins,
pubmed-meshheading:11375285-Humans,
pubmed-meshheading:11375285-Immunoglobulin G,
pubmed-meshheading:11375285-Lupus Coagulation Inhibitor,
pubmed-meshheading:11375285-Lupus Erythematosus, Systemic,
pubmed-meshheading:11375285-Male,
pubmed-meshheading:11375285-Middle Aged,
pubmed-meshheading:11375285-Multivariate Analysis,
pubmed-meshheading:11375285-Prognosis,
pubmed-meshheading:11375285-Protein C,
pubmed-meshheading:11375285-Protein S,
pubmed-meshheading:11375285-Prothrombin,
pubmed-meshheading:11375285-Seroepidemiologic Studies,
pubmed-meshheading:11375285-Statistics as Topic,
pubmed-meshheading:11375285-Thrombocytopenia,
pubmed-meshheading:11375285-Thrombosis,
pubmed-meshheading:11375285-beta 2-Glycoprotein I
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
|
|
pubmed:affiliation |
Central Laboratory for Clinical Investigation, Osaka University Hospital, 2-15 Yamadaoka, Suita, Osaka 565-0871, Japan. nojima@hp-lab.med.osaka-u.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
